Financhill
Sell
9

UNVC Quote, Financials, Valuation and Earnings

Last price:
$0.0000
Seasonality move :
61.35%
Day range:
$0.0020 - $0.0029
52-week range:
$0.0014 - $0.0099
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.2M
Avg. volume:
841.9K
1-year change:
-61.82%
Market cap:
$380.5K
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
UNVC
UNIVEC
-- -- -- -- --
AIRS
AirSculpt Technologies
$39.3M -$0.03 -10.17% -100% $2.50
CVS
CVS Health
$93.4B $1.67 4.07% 5.19% $79.29
FPCG
First Physicians Capital Group
-- -- -- -- --
IQV
IQVIA Holdings
$3.8B $2.63 3.87% 40.76% $193.97
WORX
SCWorx
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
UNVC
UNIVEC
$0.0021 -- $380.5K -- $0.00 0% --
AIRS
AirSculpt Technologies
$3.56 $2.50 $209.3M 300.71x $0.00 0% 1.20x
CVS
CVS Health
$62.78 $79.29 $79.4B 14.98x $0.67 4.24% 0.21x
FPCG
First Physicians Capital Group
$1,025.00 -- $10M -- $0.00 0% 1.40x
IQV
IQVIA Holdings
$143.54 $193.97 $24.8B 19.56x $0.00 0% 1.68x
WORX
SCWorx
$0.49 -- $1.1M -- $0.00 0% 0.24x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
UNVC
UNIVEC
-- 1.988 -- --
AIRS
AirSculpt Technologies
48.73% 3.231 53.67% 0.33x
CVS
CVS Health
45.69% 0.648 75.52% 0.59x
FPCG
First Physicians Capital Group
-- 0.000 -- --
IQV
IQVIA Holdings
70.57% 0.610 46.67% 0.72x
WORX
SCWorx
1.08% 7.270 2.61% 0.31x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
UNVC
UNIVEC
-- -- -- -- -- --
AIRS
AirSculpt Technologies
$23.4M -$1.6M -11.15% -21.01% -4.04% -$1M
CVS
CVS Health
$14.4B $3.4B 3.75% 7% 3.6% $3.8B
FPCG
First Physicians Capital Group
-- -- -- -- -- --
IQV
IQVIA Holdings
$1.3B $525M 6.62% 20.79% 12.75% $426M
WORX
SCWorx
$132.6K -$393.5K -77.97% -80.46% -51.8% -$362.6K

UNIVEC vs. Competitors

  • Which has Higher Returns UNVC or AIRS?

    AirSculpt Technologies has a net margin of -- compared to UNIVEC's net margin of -7.23%. UNIVEC's return on equity of -- beat AirSculpt Technologies's return on equity of -21.01%.

    Company Gross Margin Earnings Per Share Invested Capital
    UNVC
    UNIVEC
    -- -- --
    AIRS
    AirSculpt Technologies
    59.49% -$0.05 $150.8M
  • What do Analysts Say About UNVC or AIRS?

    UNIVEC has a consensus price target of --, signalling downside risk potential of --. On the other hand AirSculpt Technologies has an analysts' consensus of $2.50 which suggests that it could fall by -29.78%. Given that AirSculpt Technologies has higher upside potential than UNIVEC, analysts believe AirSculpt Technologies is more attractive than UNIVEC.

    Company Buy Ratings Hold Ratings Sell Ratings
    UNVC
    UNIVEC
    0 0 0
    AIRS
    AirSculpt Technologies
    0 4 0
  • Is UNVC or AIRS More Risky?

    UNIVEC has a beta of 0.070, which suggesting that the stock is 93.018% less volatile than S&P 500. In comparison AirSculpt Technologies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock UNVC or AIRS?

    UNIVEC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AirSculpt Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UNIVEC pays -- of its earnings as a dividend. AirSculpt Technologies pays out -3.05% of its earnings as a dividend.

  • Which has Better Financial Ratios UNVC or AIRS?

    UNIVEC quarterly revenues are --, which are smaller than AirSculpt Technologies quarterly revenues of $39.4M. UNIVEC's net income of -- is lower than AirSculpt Technologies's net income of -$2.8M. Notably, UNIVEC's price-to-earnings ratio is -- while AirSculpt Technologies's PE ratio is 300.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UNIVEC is -- versus 1.20x for AirSculpt Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    UNVC
    UNIVEC
    -- -- -- --
    AIRS
    AirSculpt Technologies
    1.20x 300.71x $39.4M -$2.8M
  • Which has Higher Returns UNVC or CVS?

    CVS Health has a net margin of -- compared to UNIVEC's net margin of 1.88%. UNIVEC's return on equity of -- beat CVS Health's return on equity of 7%.

    Company Gross Margin Earnings Per Share Invested Capital
    UNVC
    UNIVEC
    -- -- --
    CVS
    CVS Health
    15.22% $1.41 $141.8B
  • What do Analysts Say About UNVC or CVS?

    UNIVEC has a consensus price target of --, signalling downside risk potential of --. On the other hand CVS Health has an analysts' consensus of $79.29 which suggests that it could grow by 26.29%. Given that CVS Health has higher upside potential than UNIVEC, analysts believe CVS Health is more attractive than UNIVEC.

    Company Buy Ratings Hold Ratings Sell Ratings
    UNVC
    UNIVEC
    0 0 0
    CVS
    CVS Health
    13 8 0
  • Is UNVC or CVS More Risky?

    UNIVEC has a beta of 0.070, which suggesting that the stock is 93.018% less volatile than S&P 500. In comparison CVS Health has a beta of 0.598, suggesting its less volatile than the S&P 500 by 40.158%.

  • Which is a Better Dividend Stock UNVC or CVS?

    UNIVEC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CVS Health offers a yield of 4.24% to investors and pays a quarterly dividend of $0.67 per share. UNIVEC pays -- of its earnings as a dividend. CVS Health pays out 73.1% of its earnings as a dividend. CVS Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios UNVC or CVS?

    UNIVEC quarterly revenues are --, which are smaller than CVS Health quarterly revenues of $94.6B. UNIVEC's net income of -- is lower than CVS Health's net income of $1.8B. Notably, UNIVEC's price-to-earnings ratio is -- while CVS Health's PE ratio is 14.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UNIVEC is -- versus 0.21x for CVS Health. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    UNVC
    UNIVEC
    -- -- -- --
    CVS
    CVS Health
    0.21x 14.98x $94.6B $1.8B
  • Which has Higher Returns UNVC or FPCG?

    First Physicians Capital Group has a net margin of -- compared to UNIVEC's net margin of --. UNIVEC's return on equity of -- beat First Physicians Capital Group's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    UNVC
    UNIVEC
    -- -- --
    FPCG
    First Physicians Capital Group
    -- -- --
  • What do Analysts Say About UNVC or FPCG?

    UNIVEC has a consensus price target of --, signalling downside risk potential of --. On the other hand First Physicians Capital Group has an analysts' consensus of -- which suggests that it could fall by --. Given that UNIVEC has higher upside potential than First Physicians Capital Group, analysts believe UNIVEC is more attractive than First Physicians Capital Group.

    Company Buy Ratings Hold Ratings Sell Ratings
    UNVC
    UNIVEC
    0 0 0
    FPCG
    First Physicians Capital Group
    0 0 0
  • Is UNVC or FPCG More Risky?

    UNIVEC has a beta of 0.070, which suggesting that the stock is 93.018% less volatile than S&P 500. In comparison First Physicians Capital Group has a beta of -12.606, suggesting its less volatile than the S&P 500 by 1360.624%.

  • Which is a Better Dividend Stock UNVC or FPCG?

    UNIVEC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. First Physicians Capital Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UNIVEC pays -- of its earnings as a dividend. First Physicians Capital Group pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios UNVC or FPCG?

    UNIVEC quarterly revenues are --, which are smaller than First Physicians Capital Group quarterly revenues of --. UNIVEC's net income of -- is lower than First Physicians Capital Group's net income of --. Notably, UNIVEC's price-to-earnings ratio is -- while First Physicians Capital Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UNIVEC is -- versus 1.40x for First Physicians Capital Group. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    UNVC
    UNIVEC
    -- -- -- --
    FPCG
    First Physicians Capital Group
    1.40x -- -- --
  • Which has Higher Returns UNVC or IQV?

    IQVIA Holdings has a net margin of -- compared to UNIVEC's net margin of 6.5%. UNIVEC's return on equity of -- beat IQVIA Holdings's return on equity of 20.79%.

    Company Gross Margin Earnings Per Share Invested Capital
    UNVC
    UNIVEC
    -- -- --
    IQV
    IQVIA Holdings
    33.9% $1.40 $20.3B
  • What do Analysts Say About UNVC or IQV?

    UNIVEC has a consensus price target of --, signalling downside risk potential of --. On the other hand IQVIA Holdings has an analysts' consensus of $193.97 which suggests that it could grow by 35.14%. Given that IQVIA Holdings has higher upside potential than UNIVEC, analysts believe IQVIA Holdings is more attractive than UNIVEC.

    Company Buy Ratings Hold Ratings Sell Ratings
    UNVC
    UNIVEC
    0 0 0
    IQV
    IQVIA Holdings
    14 7 0
  • Is UNVC or IQV More Risky?

    UNIVEC has a beta of 0.070, which suggesting that the stock is 93.018% less volatile than S&P 500. In comparison IQVIA Holdings has a beta of 1.344, suggesting its more volatile than the S&P 500 by 34.416%.

  • Which is a Better Dividend Stock UNVC or IQV?

    UNIVEC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IQVIA Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UNIVEC pays -- of its earnings as a dividend. IQVIA Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios UNVC or IQV?

    UNIVEC quarterly revenues are --, which are smaller than IQVIA Holdings quarterly revenues of $3.8B. UNIVEC's net income of -- is lower than IQVIA Holdings's net income of $249M. Notably, UNIVEC's price-to-earnings ratio is -- while IQVIA Holdings's PE ratio is 19.56x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UNIVEC is -- versus 1.68x for IQVIA Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    UNVC
    UNIVEC
    -- -- -- --
    IQV
    IQVIA Holdings
    1.68x 19.56x $3.8B $249M
  • Which has Higher Returns UNVC or WORX?

    SCWorx has a net margin of -- compared to UNIVEC's net margin of -55.94%. UNIVEC's return on equity of -- beat SCWorx's return on equity of -80.46%.

    Company Gross Margin Earnings Per Share Invested Capital
    UNVC
    UNIVEC
    -- -- --
    WORX
    SCWorx
    17.45% -$0.27 $4.5M
  • What do Analysts Say About UNVC or WORX?

    UNIVEC has a consensus price target of --, signalling downside risk potential of --. On the other hand SCWorx has an analysts' consensus of -- which suggests that it could fall by --. Given that UNIVEC has higher upside potential than SCWorx, analysts believe UNIVEC is more attractive than SCWorx.

    Company Buy Ratings Hold Ratings Sell Ratings
    UNVC
    UNIVEC
    0 0 0
    WORX
    SCWorx
    0 0 0
  • Is UNVC or WORX More Risky?

    UNIVEC has a beta of 0.070, which suggesting that the stock is 93.018% less volatile than S&P 500. In comparison SCWorx has a beta of 2.355, suggesting its more volatile than the S&P 500 by 135.489%.

  • Which is a Better Dividend Stock UNVC or WORX?

    UNIVEC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SCWorx offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UNIVEC pays -- of its earnings as a dividend. SCWorx pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios UNVC or WORX?

    UNIVEC quarterly revenues are --, which are smaller than SCWorx quarterly revenues of $759.7K. UNIVEC's net income of -- is lower than SCWorx's net income of -$425K. Notably, UNIVEC's price-to-earnings ratio is -- while SCWorx's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UNIVEC is -- versus 0.24x for SCWorx. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    UNVC
    UNIVEC
    -- -- -- --
    WORX
    SCWorx
    0.24x -- $759.7K -$425K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Ginkgo Bioworks Stock a Good Buy?
Is Ginkgo Bioworks Stock a Good Buy?

Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…

Why Mobileye Might Be Wall Street’s Next Big Surprise
Why Mobileye Might Be Wall Street’s Next Big Surprise

The trend to automate vehicles started long ago when adding…

Why Is Rigetti Stock Going Up?
Why Is Rigetti Stock Going Up?

Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
71
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
99
SOC alert for May 20

Sable Offshore [SOC] is down 0.79% over the past day.

Buy
52
RGC alert for May 20

Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.

Sell
40
GWLIF alert for May 20

Great-West Lifeco [GWLIF] is up 13.42% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock